US FDA makes recommendations for influenza vaccines

After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations
The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
FDA issues flu vaccine recommendations for 2025-26 season
The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
US FDA makes recommendations for influenza vaccines to manufacturers
The U.S. Food and Drug Administration on Thursday made recommendations to vaccine manufacturers for the virus strains to be used in influenza vaccines for the 2025-2026 flu season in the United States.
Government panel steps in after FDA cancels advisory meeting on flu shot recommendations
After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the upcoming 2025-26 season.
FDA Makes Flu Vaccine Recommendations Without Convening Advisors
The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.
FDA sets flu shot recommendations without input of outside advisers
The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting that's typically held was canceled last month.
Could flu shot supply fall short this year? FDA's canceled meeting sparks worries
Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was abruptly canceled.
FDA issues flu vaccine recommendations without AdCom input
The U.S. Food and Drug Administration (FDA) has issued its recommendations to vaccine makers on which virus strains to select when manufacturing influenza (flu) vaccines for the 2025-2026 U.S. flu season.
Trump’s FDA and NIH picks clear committee, teeing up final Senate confirmation
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
Trump FDA nominee turns vaccine question on Dem, recalling controversial Biden decision
Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden ...
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...